Oncotarget Trending With Impact: Unconventional Method Effectively Targets NSCLC In a trending paper published by Oncotarget, researchers developed a divergent strategy to treat non-small... read more September 30, 2021
Oncotarget New Study: Protein Analysis Reveals Novel Role of Enzyme In Cancer Researchers discovered an enzyme, originally known to regulate the TGF-β, has a previously unreported role... read more September 30, 2021
Oncotarget Table of Contents: Oncotarget’s Volume 12, Issue #20 Read short summaries of the latest oncology-focused research published in this week’s issue of... read more September 28, 2021
Oncotarget Behind the Study: Populations of Cells Resistant to EMT Dr. Herbert Levine and Dr. Mohit Kumar Jolly describe their research that... read more September 27, 2021
Oncotarget Behind the Study: Evaluations in TRAMP Prostate Cancer Model Dr. Yves Chabu from the Department of Biological Sciences at the University of Missouri describes... read more September 20, 2021
Oncotarget Oncotarget Testimonial: Dr. Yves Chabu Below is a transcript of the testimonial by Dr. Yves... read more September 17, 2021
Oncotarget New Study: Nanoparticles Target Acute Myeloid Leukemia Researchers developed a nanoparticle-based T cell engager (nanoTCE) technology believed to be capable of targeting... read more September 15, 2021
Oncotarget Table of Contents: Oncotarget’s Volume 12, Issue #19 Read short summaries of the latest oncology-focused research published in this week’s issue of... read more September 14, 2021
Oncotarget Behind the Study: EMT, Endothelial Cells & Tumor Growth Dr. Tapasree Roy Sarkar from the Department of Biology at Texas A&M University... read more September 13, 2021
Oncotarget Trending With Impact: EMT-Induced Stemness Promotes Tumor Growth Researchers conducted a study to show how epithelial-to-mesenchymal transitions (EMT) can promote tumor growth and... read more September 9, 2021